Strides Shasun gets approval for Omega-3-Acid Ethyl Esters Softgel capsules

From USFDA
Strides Shasun has received approval from USFDA for Omega-3-Acid Ethyl Esters Softgel capsules, a generic version of Lovaza.The US market for Lovaza is approximately USD 300 million per annum as per IMS.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 20 2017 | 9:11 AM IST
